Overview
Post-inflammatory pulmonary fibrosis refers to the development of fibrosis in the lungs following an inflammatory insult, often seen in the context of asymptomatic or mild COVID-19 infections 2. This condition can manifest as pulmonary fibrosis without preceding overt respiratory symptoms.Diagnosis
Clinical evaluation to exclude other causes of pulmonary fibrosis 2.
High-resolution computed tomography (HRCT) showing characteristic fibrotic changes 2.
Pulmonary function tests (PFTs) indicating restrictive or mixed ventilatory defects 2.
Histopathological examination of lung biopsy may be necessary for definitive diagnosis 2.Management
Early identification and management of underlying inflammatory conditions 3.
Supportive care including oxygen therapy and pulmonary rehabilitation 3.
Antifibrotic medications such as nintedanib or pirfenidone may be considered based on severity 3.
Monitoring and management of comorbidities to prevent exacerbation 3.Special Populations
Pregnancy: No specific data provided in the abstracts [].
Pediatrics: No specific data provided in the abstracts [].
Elderly: Increased vigilance due to higher risk of comorbidities and poorer tolerance to treatments 3.
Comorbidities: Management should consider interactions and exacerbation risks from existing conditions 3.Key Recommendations
Evaluate patients with unexplained pulmonary fibrosis for a history of asymptomatic or mild COVID-19 infection to consider post-inflammatory pulmonary fibrosis 2 (Evidence: Weak).
Initiate supportive care measures including pulmonary function monitoring and rehabilitation in diagnosed cases 3 (Evidence: Moderate).
Consider antifibrotic therapies in severe cases, guided by clinical guidelines and patient-specific factors 3 (Evidence: Moderate).References
1 Demessant-Flavigny AL, Petkar G, Jodun D, Le Dantec G, Le Floc'h C, Kerob D. Efficacy of a 2-MNG-Containing Depigmenting Serum in the Treatment of Post-Inflammatory Hyperpigmentation. Journal of cosmetic dermatology 2025. link
2 Antony T, Vishak Acharya K, Unnikrishnan B, Keerthi NS. A silent march-Post covid fibrosis in asymptomatics - A cause for concern?. The Indian journal of tuberculosis 2023. link
3 Naik P. Getting to the Core of Contemporary Therapies for Post-Inflammatory Hyperpigmentation. Journal of drugs in dermatology : JDD 2022. link
4 Lindgren AL, Austin AH, Welsh KM. The Use of Tranexamic Acid to Prevent and Treat Post-Inflammatory Hyperpigmentation. Journal of drugs in dermatology : JDD 2021. link
5 Delgado RE, Torre Mde L. Use of fractional laser in mixed-race patients. Facial plastic surgery : FPS 2013. link
6 Spencer H. The pulmonary plasma cell/histiocytoma complex. Histopathology 1984. link